Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia
A Standard patent application filed on 06 January 1998 credited to Fox, David Nathan Abraham

Details

Application number :

62088  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of begnin prostatic hyperplasia  

Inventor :

Fox, David Nathan Abraham  

Agent name :

SPRUSON & FERGUSON  

Address for service :

GPO Box 3898 SYDNEY NSW 2001  

Filing date :

06 January 1998  

Associated companies :

 

Applicant name :

Pfizer Inc.  

Applicant address :

235 East 42nd Street New York NY 10017 United States Of America  

Old name :

 

Original Source :

Go  

Same Inventor

• Pharmaceutical combination of PDE5 inhibitors with ACE inhibitors
• Combination of PDE5 inhibitors with angiotensin II receptor...
• Quinoline and quinazoline compounds useful in therapy
• 5,7-diaminopyrazolo[4,3-D]pyrimidines useful in the treatment of...